VuCOMP Announces Milestone for Development of Computer-Aided Detection for Breast Tomosynthesis

share Share

VuCOMP, Inc., leading developer of advanced computer vision systems for the detection of breast cancer, is pleased to announce the successful completion of the development of structured reporting (SR) for CAD marks for digital breast tomosynthesis images.

With this feature, VuCOMP has added the tomosynthesis slice information into the SR so that workstations will have the ability to display the CAD marks directly on the tomosynthesis slices. Additionally, tomosynthesis findings will be shown as enhanced marks on the 2D images.

VuCOMP is working closely with the workstation vendors to continue to enhance the integration process.

This feature will be made available as part of VuCOMP’s M-Vu CAD System for breast tomosynthesis. The M-Vu CAD System for breast tomosynthesis is currently under review by the Food and Drug Administration (FDA), pending approval.

Jim Pike, President and CTO of VuCOMP, stated, “Integration of our CAD markings on tomosynthesis images via the various workstations currently deployed is a major milestone in our development of the first commercially available CAD solution for digital breast tomosynthesis. The SR output is a critical step as we continue to progress down the development path. It has been important for us to work out the details of displaying marks on tomosynthesis slices so that once the FDA approves a CAD system for tomosynthesis, we will have a mechanism in place for appropriate display on the slices.”

The M-Vu® CAD system was the first mammography CAD product to meet the rigorous FDA standard that recommends comprehensive reader studies to prove the effectiveness of CAD systems. VuCOMP continues to provide systematic product updates, fulfilling the company’s commitment to ongoing enhancements for its customers.

Source credit: VuCOMP, Inc.

«« MRI Contrast Agents: Study Highlights 'Safety Issue'


Mets Imaging in Early Breast Cancer Common Despite Guidelines »»

Published on : Thu, 25 Jun 2015



Related Articles
VuCOMP to Showcase Industry-Leading Computer Vision Systems for the Detection of Breast Cancer

VuCOMP, Inc., leading developer of advanced computer vision systems for the detection of breast cancer, has announced that it... Read more

Hologic

Mammography providers say Hologic stands out for technology innovation, high image quality, and C-View™ dose-reduction technology... Read more

Hologic to Showcase Award-Winning Breast Screening and Interventional Solutions at RSNA 2016

--New products spotlight Hologic's leading tomosynthesis technology, including the world's first dedicated prone biopsy system... Read more

detection, CAD solution, VuCOMP, tomosynthesis VuCOMP is working closely with the workstation vendors to continue to enhance the integration process.This feature will be made available as part of VuCOMP’s M-Vu CAD System for breast tomosynthesis.

No comment


Please login to leave a comment...

Highlighted Products